European Companies Search Engine
UK funding (£1,880,175): Manufacture of complex protein polymers for industry and medicine Ukri 1 May 2015 UK Research and Innovation, United Kingdom
Overview
Text
Manufacture of complex protein polymers for industry and medicine
| Abstract | Modern biomedical science and clinical medicine rely increasingly upon the growth of cells outside of the body. In this way we can perform animal free experiments which are highly informative about a range of diseases including cancer, arthritis and dementia. We can also use these artificial cell cultures to make new drugs and there is a growing industry making such drugs as Herceptin for cancer and vaccines against hepatitis. Finally we now have the hope of stem cells to create a range of regenerative medicine cures for a range of conditions. In all these cases the cells are growing outside of the body and often require an external scaffolding of molecules to support their normal growth patterns. Currently these scaffolds are every expensive and of limited technical complexity. This project will create a cheap, pure and highly flexible source of polymeric proteins which can be built into a range of products to accelerate and stabilise the growth of cells in culture and assist all the technologies mentioned above. |
| Category | Research Grant |
| Reference | BB/M018318/1 |
| Status | Closed |
| Funded period start | 01/05/2015 |
| Funded period end | 31/07/2021 |
| Funded value | £1,880,175.00 |
| Source | https://gtr.ukri.org/projects?ref=BB%2FM018318%2F1 |
Participating Organisations
| NEWCASTLE UNIVERSITY | |
| University of Cambridge | |
| CELL AND GENE THERAPY CATAPULT | |
| Cell Therapy Catapult | |
| Laboratory for Vascular Translational Science (LVTS) |
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Newcastle University, Newcastle Upon Tyne.
